3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
272
Leukemia
194
Precursor Cell Lymphoblastic Leukemia-Lymphoma
131
Lymphoma
108
Congenital Abnormalities
68
Myelodysplastic Syndromes
63
Leukemia, Myelomonocytic, Acute
60
Leukemia, Monocytic, Acute
58
Leukemia, Erythroblastic, Acute
56
Leukemia, Megakaryoblastic, Acute
54
Lymphoma, Non-Hodgkin
51
Burkitt Lymphoma
44
Lymphoma, Mantle-Cell
42
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma, Follicular
33
Leukemia, Myelomonocytic, Chronic
28
Anemia, Refractory, with Excess of Blasts
27
Hodgkin Disease
26
Recurrence
25
Lymphoma, Large-Cell, Immunoblastic
25
Leukemia, Lymphocytic, Chronic, B-Cell
25
Blast Crisis
24
Leukemia, Eosinophilic, Acute
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Myeloproliferative Disorders
17
Leukemia, Basophilic, Acute
17
Lymphoma, B-Cell, Marginal Zone
16
Leukemia, Promyelocytic, Acute
16
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Accelerated Phase
14
Interventions
Alemtuzumab
2
tocilizumab
1
Whole-Body Irradiation
1
Polymerase Chain Reaction
1
Methotrexate
1
In Situ Hybridization
1
Immunohistochemistry
1
Flow Cytometry
1
Etoposide
1
Emapalumab
1
Dexamethasone
1
Data Collection
1
Cytogenetic Analysis
1
Cytarabine
1
Cyclophosphamide
1
Calcium Dobesilate
1
Blotting, Western
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphohistiocytosis, Hemophagocytic
×
Cytarabine
×
Clear all
NCT00368355
2020-01-21
MOHEL
Baylor College of Medicine
Phase 2
Completed
46 enrolled
12 charts